| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |